Thanh Hoang

Employment

• University of Queensland Diamantina Institute for Cancer Immunology and Metabolic Medicine PhD student
  2015 - Present
• Hue University of Medicine and Pharmacy, Hue University Lecturer/PhD
  2011 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Successful treatment of Epstein–Barr virus–associated primary central nervous system lymphoma due to post‐transplantation lymphoproliferative disorder, with ibrutinib and third‐party Epstein–Barr virus–specific T cells
  American Journal of Transplantation 2021 DOI: 10.1111/ajt.16628
  +Save
• EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
  Maher K. Gandhi, Thanh Hoang, Soi Cheng Law +25 more
  Blood 2021 DOI: 10.1182/blood.2020008520
  +Save
• Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration
  Journal of Clinical Oncology 2019 DOI: 10.1200/jco.18.02365
  +Save
• A laboratory study of primary central nervous system lymphoma
  2019 DOI: 10.14264/uql.2019.955
  +Save
• EBV+ CNS LYMPHOMAS HAVE A DISTINCTIVE TUMOR MICROENVIRONMENT AND GENETIC PROFILE, WHICH IS AMENABLE TO COMBINATION 3RD PARTY EBV-SPECIFIC CTL AND IBRUTINIB THERAPY
  Hematological Oncology 2019 DOI: 10.1002/hon.91_2629
  +Save
• The Tumour Microenvironment as an Independent Prognostic Biomarker in Follicular Lymphoma
  Internal Medicine Journal 2018 DOI: 10.1111/imj.2_13826
  +Save
• The Tumor Microenvironment Is Independently Prognostic of Conventional and Clinicogenetic Risk Models in Follicular Lymphoma
  Blood 2017 DOI: 10.1182/blood.v130.suppl_1.728.728
  +Save